Integrating cognitive behavioral therapy and pharmacotherapy in the treatment of adolescent depression

Golda S. Ginsburg*, Anne Marie Albano, Robert L. Findling, Christopher Kratochvil, John Walkup

*Corresponding author for this work

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Recent evidence from the Treatment for Adolescents With Depression Study (TADS) suggests that combining cognitive behavioral and pharmacological treatments holds the most promise for ameliorating depression among adolescents. This article describes lessons learned during the TADS trial about how to integrate these two treatments in the care of adolescents with depression. Toward this end, both common and unique components of each perspective's approach to data gathering and treatment selection are presented. Procedures for changing "dosage" and adding adjunctive treatments to each of these interventions are also discussed. Finally, issues related to sequencing treatments and guidelines for sharing information across treatment providers are offered.

Original languageEnglish (US)
Pages (from-to)252-262
Number of pages11
JournalCognitive and Behavioral Practice
Volume12
Issue number2
DOIs
StatePublished - Jan 1 2005

Fingerprint

Cognitive Therapy
Depression
Drug Therapy
Therapeutics
Information Dissemination
Pharmacology
Guidelines

ASJC Scopus subject areas

  • Clinical Psychology

Cite this

Ginsburg, Golda S. ; Albano, Anne Marie ; Findling, Robert L. ; Kratochvil, Christopher ; Walkup, John. / Integrating cognitive behavioral therapy and pharmacotherapy in the treatment of adolescent depression. In: Cognitive and Behavioral Practice. 2005 ; Vol. 12, No. 2. pp. 252-262.
@article{5da33bb3e0b34d78a675f2ebe767c508,
title = "Integrating cognitive behavioral therapy and pharmacotherapy in the treatment of adolescent depression",
abstract = "Recent evidence from the Treatment for Adolescents With Depression Study (TADS) suggests that combining cognitive behavioral and pharmacological treatments holds the most promise for ameliorating depression among adolescents. This article describes lessons learned during the TADS trial about how to integrate these two treatments in the care of adolescents with depression. Toward this end, both common and unique components of each perspective's approach to data gathering and treatment selection are presented. Procedures for changing {"}dosage{"} and adding adjunctive treatments to each of these interventions are also discussed. Finally, issues related to sequencing treatments and guidelines for sharing information across treatment providers are offered.",
author = "Ginsburg, {Golda S.} and Albano, {Anne Marie} and Findling, {Robert L.} and Christopher Kratochvil and John Walkup",
year = "2005",
month = "1",
day = "1",
doi = "10.1016/S1077-7229(05)80030-6",
language = "English (US)",
volume = "12",
pages = "252--262",
journal = "Cognitive and Behavioral Practice",
issn = "1077-7229",
publisher = "Elsevier Inc.",
number = "2",

}

Integrating cognitive behavioral therapy and pharmacotherapy in the treatment of adolescent depression. / Ginsburg, Golda S.; Albano, Anne Marie; Findling, Robert L.; Kratochvil, Christopher; Walkup, John.

In: Cognitive and Behavioral Practice, Vol. 12, No. 2, 01.01.2005, p. 252-262.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Integrating cognitive behavioral therapy and pharmacotherapy in the treatment of adolescent depression

AU - Ginsburg, Golda S.

AU - Albano, Anne Marie

AU - Findling, Robert L.

AU - Kratochvil, Christopher

AU - Walkup, John

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Recent evidence from the Treatment for Adolescents With Depression Study (TADS) suggests that combining cognitive behavioral and pharmacological treatments holds the most promise for ameliorating depression among adolescents. This article describes lessons learned during the TADS trial about how to integrate these two treatments in the care of adolescents with depression. Toward this end, both common and unique components of each perspective's approach to data gathering and treatment selection are presented. Procedures for changing "dosage" and adding adjunctive treatments to each of these interventions are also discussed. Finally, issues related to sequencing treatments and guidelines for sharing information across treatment providers are offered.

AB - Recent evidence from the Treatment for Adolescents With Depression Study (TADS) suggests that combining cognitive behavioral and pharmacological treatments holds the most promise for ameliorating depression among adolescents. This article describes lessons learned during the TADS trial about how to integrate these two treatments in the care of adolescents with depression. Toward this end, both common and unique components of each perspective's approach to data gathering and treatment selection are presented. Procedures for changing "dosage" and adding adjunctive treatments to each of these interventions are also discussed. Finally, issues related to sequencing treatments and guidelines for sharing information across treatment providers are offered.

UR - http://www.scopus.com/inward/record.url?scp=32444436277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32444436277&partnerID=8YFLogxK

U2 - 10.1016/S1077-7229(05)80030-6

DO - 10.1016/S1077-7229(05)80030-6

M3 - Review article

VL - 12

SP - 252

EP - 262

JO - Cognitive and Behavioral Practice

JF - Cognitive and Behavioral Practice

SN - 1077-7229

IS - 2

ER -